Education
About Us
Working with TipRanks
Follow Us
Sonic Healthcare Limited (SKHHY)
OTHER OTC:SKHHY
SKHHY Stock Chart & Stats
$14.96
-$0.18(-1.00%)
At close: 4:00 PM EST
$14.96
-$0.18(-1.00%)
Day’s Range― - ―
52-Week Range$13.39 - $18.71
Previous CloseN/A
Volume5.11K
Average Volume (3M)19.70K
Market Cap
$8.02B
Enterprise Value$18.78B
Total Cash (Recent Filing)$556.57M
Total Debt (Recent Filing)$7.34B
Price to Earnings (P/E)22.6
Beta0.42
Next Earnings
Aug 26, 2026EPS Estimate
0.48Next Dividend Ex-DateN/A
Dividend Yield4.08%
Share Statistics
EPS (TTM)0.35
Shares Outstanding494,237,950
10 Day Avg. Volume29,893
30 Day Avg. Volume19,698
Financial Highlights & Ratios
PEG Ratio0.00
Price to Book (P/B)1.57
Price to Sales (P/S)1.35
P/FCF Ratio13.57
Enterprise Value/Market Cap2.34
Enterprise Value/Revenue2.41
Enterprise Value/Gross Profit8.47
Enterprise Value/Ebitda14.22
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.86
Revenue Forecast (FY)$7.74B
Bulls Say, Bears Say
Bulls Say
Free Cash Flow StrengthMaterial FCF growth and strong earnings-to-cash conversion indicate durable cash generation. This supports dividends, maintenance capex, targeted acquisitions and debt reduction without relying on equity markets, giving management sustained financial flexibility across cycles.
Consistent Organic Growth And Margin GainsMid-single-digit organic growth across major markets with ~30bp margin expansion shows resilient demand and operational leverage. Sustainable margin improvement suggests scalable lab and imaging platforms and ongoing synergies from recent integrations.
Balance-sheet Headroom And Capital DisciplineMaintaining investment-grade leverage targets with ~AUD1bn headroom and active property monetisation gives scope to fund strategic capex, selective M&A and shareholder returns while protecting credit metrics, supporting medium-term financial resilience.
Bears Say
U.S. Margin Pressure And RestructuringStructural underperformance in the U.S., low organic growth and ongoing rationalisation create a persistent drag on group margins. Restructuring costs and slower recovery of volumes/collections can reduce consolidated profitability for multiple quarters.
Billing Disruptions Raised Net Debt And Working CapitalDisrupted U.S. billing/collections materially increased debtors and short-term liabilities, elevating net debt and working capital requirements. Until collections normalise, interest costs and liquidity flexibility remain constrained, delaying deleveraging plans.
Regulatory Uncertainty In GermanyPending private fee-schedule reform in Germany creates persistent reimbursement risk in a key growth market. Uncertain timing and magnitude of changes hinder pricing, margin forecasting and investment planning, potentially compressing future profitability.
Sonic Healthcare News
SKHHY FAQ
What was Sonic Healthcare Limited’s price range in the past 12 months?
Sonic Healthcare Limited lowest stock price was $13.39 and its highest was $18.71 in the past 12 months.
What is Sonic Healthcare Limited’s market cap?
Sonic Healthcare Limited’s market cap is $8.02B.
When is Sonic Healthcare Limited’s upcoming earnings report date?
Sonic Healthcare Limited’s upcoming earnings report date is Aug 26, 2026 which is in 181 days.
How were Sonic Healthcare Limited’s earnings last quarter?
Sonic Healthcare Limited released its earnings results on Feb 18, 2026. The company reported $0.353 earnings per share for the quarter, missing the consensus estimate of $0.357 by -$0.004.
Is Sonic Healthcare Limited overvalued?
According to Wall Street analysts Sonic Healthcare Limited’s price is currently Overvalued.
Does Sonic Healthcare Limited pay dividends?
Sonic Healthcare Limited pays a Semiannually dividend of $0.374 which represents an annual dividend yield of 4.08%. See more information on Sonic Healthcare Limited dividends here
What is Sonic Healthcare Limited’s EPS estimate?
Sonic Healthcare Limited’s EPS estimate is 0.48.
How many shares outstanding does Sonic Healthcare Limited have?
Sonic Healthcare Limited has 494,237,950 shares outstanding.
What happened to Sonic Healthcare Limited’s price movement after its last earnings report?
Sonic Healthcare Limited reported an EPS of $0.353 in its last earnings report, missing expectations of $0.357. Following the earnings report the stock price went up 9.653%.
Which hedge fund is a major shareholder of Sonic Healthcare Limited?
Currently, no hedge funds are holding shares in SKHHY
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Sonic Healthcare Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-19.48%
12-Months-Change
Fundamentals
Return on Equity
6.18%
Trailing 12-Months
Asset Growth
6.16%
Trailing 12-Months
Company Description
Sonic Healthcare Limited
Sonic Healthcare Limited offers medical diagnostic services in Australia. The company provides laboratory medicine/pathology; diagnostic imaging/radiology, including magnetic resonance imaging, computed tomography (CT), ultrasound, X-ray, mammography, nuclear medicine, PET CT, interventional procedures, and bone mineral densitometry; and primary care medical services comprising general practice services, occupational health services, remote health services, community and home nursing services, primary care research programs, health assessment technologies, clinical trials, and chronic disease management programs to clinicians, hospitals, community health services, and their patients. It also offers administrative services and facilities to medical practitioners. The company operates in Australia, New Zealand, the United Kingdom, the United States, Germany, Switzerland, Belgium, and Ireland. Sonic Healthcare Limited was incorporated in 1934 and is headquartered in Sydney, Australia.
SKHHY Company Deck
SKHHY Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
Overall the call presents a largely positive operational and financial picture: strong H1 results (revenue, EBITDA, net profit), maintained full-year EBITDA guidance, margin improvement at group level (+30 bps), successful integration progress in major acquisitions (Germany LADR and Swiss deals), and continued organic growth across several markets (Australia, Germany, UK, Radiology). Offsetting these positives are concentrated challenges in the U.S. (margin pressure, restructuring and delayed revenue collection benefits), elevated short-term net debt and working capital due to acquisitions and the Change Healthcare billing disruption, FX headwinds for H2, and some regulatory/wage uncertainties (Germany GOA reform and Australian Fair Work outcomes). Management has clear remediation and capital management plans (operating review, sale-and-leaseback program, potential buybacks) and has retained guidance, supporting a constructive outlook despite identifiable near-term risks.View all SKHHY earnings summariesTechnical Analysis
Ownership Overview
―
Insiders
<0.01% Other Institutional Investors
99.99% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---